Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202412
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.

<<
  • 202412
  • 202411
  • 202410
  • 202409
  • 202408
  • 202407
  • 202406
  • 202405
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 201704

Price of this issue :
USD 98

Published on 27th April, 2017

Published on 27th April, 2017

On 6 April, 2017, Shaanxi released its 2017 plan for water pollution prevention and control. In order to meet standards and improve indexes for water quality, special actions will be targeted at heavy-polluting enterprises, such as API manufacturing. In this context, small-sized vitamin producers in the province may be greatly impacted and even forced to close business, improving production concentration in the overall vitamin industry.

Published on 27th April, 2017

In 2016, most vitamin products saw price surge due to environmental regulations, and in 2017, the price rise is estimated to continue under stricter environmental regulations.

Published on 27th April, 2017

On 8 April, Kingdomway released 2016 financial report which showed YoY increase in revenue and net profit. Such a performance was a result of YoY increases in both price and sales of VA. In addition, Kingdomway is working on sport Big Health to make it another profit driver.

Published on 27th April, 2017

The CFDA announced its order to modify package inserts for lipid-lowering niacin medications on 23 March, 2017. Yet, the 200+ involved producers may just be impacted slightly, given the small market size of related preparations.

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 26th April, 2017

Published on 24th April, 2017

According to CCM's price monitoring, the quoted price of VK3 increases 85.41%-92.55% MoM, due to strict environmental regulation and tightened supply of raw materials. Meanwhile, the price will continue growing provided that the above two factors cannot be solved in a short time.

Published on 24th April, 2017

According to the China Customs, VE saw reduced volume and increased price of export in Feb. 2017 like in H2 2016. In H1 2017, VE export is estimated to keep the same trend due to strict environmental regulation and that the production is not at full capacity.

Published on 24th April, 2017

On 12 April, Zhejiang Medicine released 2016 financial report which showed net profit up 178.18%, and that is a result of rising price of VA and VE. Zhejiang Medicine commented that the main factor for limited production was environmental regulation, but they were less influenced due to much environmental protection work.

Published on 13th April, 2017

Published on 13th April, 2017

Published on 12th April, 2017

On 6 April, Northeast Pharm released 2016 financial report which showed its year-on-year financial performance. The growth comes from performance increases of three major segments, especially the APIs (mainly VC) which makes a financial turnaround. Under the influence of environmental regulations in 2017, the price of VC is estimated to stay high; more investment will be used on relocation plan for VC.

Published on 12th April, 2017

On 1 April, Yifan Pharmaceutical released its 2016 financial report which showed large improvement of financial performance, owing to year-on-year growth of VB5 gross profit margin, increases of revenue and net profit in the section of pharmaceutical formulations. Yifan Pharmaceutical will also welcome performance growth in H1 2017, thanks to high price of VB5 as well as business integration, upgrading and transformation.

Published on 12th April, 2017

On 28 March, Zhejiang NHU released 2016 financial report. According to the report, 2016 net profit soared in 2016, due to surging price of VA and VE as well as gross profit increase of main products. In H1 2017, the price of VA and VE will slightly go down, therefore, its performance on vitamins nutrients is estimated the same as in H1 2016 but will see year-on-year growth in H1, owing to price rise of methionine.

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement